TradeGel
Antibacterial Skin Protection Solution
Company Overview
Snapshot
Founded in January 2014 by D. Glikman, TradeGel operates with 1–10 employees. The company holds one patent for its technology. TradeGel ceased operations in February 2022.
Business overview
TradeGel develops Hetromistin Instant Crystal HetroCleaner, an antiseptic, antibacterial, and hypoallergenic solution for daily skin protection. This clinically proven product is designed to keep skin healthy and clean, helping to combat various infections, including those relevant to COVID-19. The solution is odorless, non-staining, and does not require rinsing, featuring a balanced pH level. Hetromistin also functions as a multifunctional disinfection solution for unisex use, reducing the risk of fungal infections after outdoor activities or public visits. The company operates within the Health Tech & Life Sciences sector, specifically focusing on pharmaceuticals, therapeutics, and dermatology, serving B2B2C, B2B, and B2C markets primarily in Israel.
Log in to access full profile ›Company Intelligence Q&A
- What is TradeGel's core product?
- TradeGel's core product is Hetromistin Instant Crystal HetroCleaner, an antiseptic, antibacterial, and hypoallergenic solution for daily skin protection.
- When was TradeGel founded?
- TradeGel was founded in January 2014.
- Who founded TradeGel?
- TradeGel was founded by D. Glikman, who also serves as Sales Executive.
- What is the status of TradeGel's operations?
- TradeGel ceased to operate in February 2022.
- What certifications does TradeGel's product hold?
- TradeGel's Hetromistin formula has protected IP and is GMP certified and approved by the Israeli Ministry of Health.